Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Nishant Shah

Preventive Cardiology · Duke Hospital

View

Dr. Amit Khera

Preventive Cardiology · UT Southwestern

View

Dr. Martha Gulati

Preventive Cardiology · Houston Methodist

View

Dr. Pradeep Natarajan

Preventive Cardiology · MGH

View

Dr. Christopher Cannon

Preventive Cardiology · BWH

View

Dr. Nicholas Marston

Preventive Cardiology · BWH

View

Dr. Dorairaj Prabhakaran

General Cardiology

View

Dr. Pugazhendhi Vijayaraman

EP · Geisinger

View

Dr. Robert Schaller

EP · HUP

View

Dr. Trey Woods

General Cardiology · Emory Healthcare

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JPDr. Jeffrey Probstfield

    Dr. Jeffrey Probstfield

    Cardiology · Preventive Cardiology
    jeffreyprobstfield

    Research

    Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension: A Randomized Controlled Trial

    2025

    Via Chest

    Research

    Scoping review of echocardiographic parameters associated with diagnosis and prognosis after resuscitated sudden cardiac arrest

    2023

    Via Resuscitation

    Research

    Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial

    2023

    Via Diabetes, Obesity & Metabolism

    Research

    Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial

    2023

    Via American Heart Journal

    Research

    Diagnostic yield, safety, and outcomes of Head-to-pelvis sudden death CT imaging in post arrest care: The CT FIRST cohort study

    2023

    Via Resuscitation

    Research

    Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes

    2022

    Via Journal of the American Heart Association

    Research

    Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study

    2022

    Via Diabetes Care

    Research

    Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial

    2022

    Via European Journal of Heart Failure

    Research

    Reply to the letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial'

    2022

    Via European Journal of Heart Failure

    Research

    Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial

    2022

    Via European Heart Journal. Cardiovascular Pharmacotherapy

    Research

    Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease

    2021

    Via Heart

    Research

    Early head-to-pelvis computed tomography in out-of-hospital circulatory arrest without obvious etiology

    2021

    Via Academic Emergency Medicine

    Research

    Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries

    2021

    Via Circulation

    Research

    Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease

    2021

    Via Heart (British Cardiac Society)

    Research

    Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects

    2021

    Via Arteriosclerosis, Thrombosis, and Vascular Biology